Brief: Novo Nordisk Submits Updated Proposal To Acquire Metsera
Nov 4 (Reuters) - Novo Nordisk A/S NOVOb.CO: NOVO NORDISK SUBMITS UPDATED PROPOSAL TO ACQUIRE METSERA, INC. CONFIRMS THAT IT HAS SUBMITTED AN UPDATED, UNSOLICITED PROPOSAL TO ACQUIRE METSERA UPDATED PROPOSAL HAS BEEN DECLARED SUPERIOR BY METSERA'S BOARD OF DIRECTORS TO BUY METSERA SHARES AT $62.20 PER SHARE PROPOSAL SUBJECT TO TERMS OF PFIZER'S MERGER AGREEMENT Source text: ID:nGNEbtJV2G Further company coverage: [NOVOb.CO] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up